Insider Selling: Addus HomeCare (NASDAQ:ADUS) Director Sells 150 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 150 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $115.18, for a total value of $17,277.00. Following the completion of the transaction, the director owned 3,700 shares in the company, valued at $426,166. This represents a 3.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Esteban Lopez also recently made the following trade(s):

• On Friday, December 5th, Esteban Lopez sold 166 shares of Addus HomeCare stock. The shares were sold at an average price of $112.78, for a total transaction of $18,721.48.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded down $1.65 during trading hours on Tuesday, hitting $113.49. 138,318 shares of the company’s stock were exchanged, compared to its average volume of 182,430. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of 24.30, a PEG ratio of 1.54 and a beta of 0.94. The company’s 50-day moving average price is $115.81 and its 200-day moving average price is $113.83.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The business had revenue of $362.30 million for the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The firm’s revenue for the quarter was up 25.0% compared to the same quarter last year. During the same period last year, the business earned $1.30 earnings per share. On average, sell-side analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CIBC Bancorp USA Inc. acquired a new stake in Addus HomeCare in the 3rd quarter valued at about $228,000. Danske Bank A S acquired a new position in shares of Addus HomeCare during the third quarter worth approximately $883,000. Virtus Advisers LLC bought a new stake in shares of Addus HomeCare during the third quarter valued at approximately $336,000. Wasatch Advisors LP increased its holdings in shares of Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares in the last quarter. Finally, Wexford Capital LP acquired a new stake in shares of Addus HomeCare in the third quarter valued at approximately $41,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on ADUS shares. Stephens reissued an “overweight” rating and issued a $140.00 price target on shares of Addus HomeCare in a research report on Wednesday, September 3rd. UBS Group initiated coverage on Addus HomeCare in a research note on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective for the company. BMO Capital Markets initiated coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price on the stock. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Finally, Barclays increased their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $137.11.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.